The Hydropothecary Corporation (Hydropothecary Stock Quote, Chart, News: TSXV:THCX) has announced a commercial agreement with the Société des alcools … [Read more...] about The Hydropothecary Corporation has 111% upside, GMP Securities says
Your company can reach thousands of cannabis sector investors by becoming the exclusive annual sponsor of this section. Contact us for details.
Investors looking for a pot stock with upside should look no further than MedReleaf (MedReleaf Stock Quote, Chart, News: TSX:LEAF), Echelon Wealth … [Read more...] about MedReleaf is nearly a double from here, Echelon says
The completion of a new distribution deal has Canaccord Genuity analyst Matt Bottomley feeling bullish about The Hydropothecary Corp (The … [Read more...] about The Hydropothecary Corp gets price target raised to $6.25 at Canaccord Genuity
With the stock down more than 40 per cent since its January peak, GMP Securities analyst Martin Landry says its time to buy Canopy Growth Corp. … [Read more...] about Canopy Growth Corp. stock price pullback means it’s time to buy, GMP says
With the opening this week of its fourth cannabis dispensary in Arizona and a potential doubling of its production capacity in the state, medical … [Read more...] about MPX Bioceutical is a Buy, says Echelon Wealth
The legalization of recreational marijuana may be now just a few months away, but for those Canadians not interested in smoking their pot, the … [Read more...] about The cannabis edibles market will be huge. But when will it be legal?
After a three-month bout of profit taking in the cannabis sector, the bottom may have finally been reached for some stocks, says analyst Javed Mirza … [Read more...] about It’s time to get back into marijuana stocks, says Canaccord Genuity
With a strong balance sheet thanks and a share price that’s temptingly low, Cronos Group (Cronos Group Stock Quote, Chart, News; TSXV:CRON, … [Read more...] about Buy Cronos Group on weakness, GMP Securities says
Analysts from Echelon Wealth Partners Friday released their top picks for the second quarter of 2018, and analyst Russell Stanley has his eyes on … [Read more...] about Canntrust Holdings’ share price is “nonsensical”, Echelon says
Q1 of 2018 was a memorable one in the cannabis space, to be sure, with upward momentum to start off January, followed by a equally sharp decline in … [Read more...] about Canopy Growth Corp. is a Top Pick for the second quarter at PI Financial